ۺŮ

Statements and guidelines directory

Looking for a specific guideline? On a desktop, type Ctrl-F (find) and search for a keyword, or use your smartphone browser’s ‘find on page’ feature.

Obstetrics

Fetal surveillance

Care of Women with Decreased Fetal MovementsۺŮ endorsed
Home Fetal Heart MonitoringۺŮ endorsed
Intrapartum Fetal Surveillance Clinical Guideline (4th edition)ۺŮ
Intrapartum Fetal Surveillance Clinical Guideline (Clinical Algorithm)ۺŮ

General

Diethylstilboestrol (DES) Exposure In Utero (C-Obs 56)ۺŮ
Exercise During Pregnancy (C-Obs 62)ۺŮ
The Use of Misoprostol in Obstetrics and Gynaecology (C-Obs 12)ۺŮ
Substance Use in Pregnancy (C-Obs 55) — under reviewۺŮ
Altruistic and Directed Umbilical Cord Blood Banking for Families at Risk (C-Obs 18)ۺŮ
Pregnancy GuidelinesۺŮ endorsed
Australian Principles of Bereavement Care ۺŮ endorsed
ۺŮ endorsed
ۺŮ endorsed
Caring for Families Experiencing Stillbirth: Part 1
Diagnosis to Birth
Useful clinical
Guidance
Caring for Families Experiencing Stillbirth: Part 2
The Birth
Useful clinical
Guidance
Caring for Families Experiencing Stillbirth: Part 3
Care Following Birth
Useful clinical
Guidance

Infections in pregnancy

Management of Hepatitis C in Pregnancy (C-Obs 51)ۺŮ
Management of Hepatitis B in Pregnancy (C-Obs 50)ۺŮ
Prevention of Congenital Cytomegalovirus (CMV) Infection (C-Obs 64) — interim update Jul ۺŮ 2023ۺŮ
Management of Perinatal InfectionsۺŮ endorsed
Chickenpox in PregnancyUseful Clinical
Guidance
Bacterial Sepsis in PregnancyUseful Clinical
Guidance
Management of Varicella Infection (Chickenpox) in PregnancyUseful Clinical
Guidance

Intrapartum care, labour and birth

Home Births (C-Obs 2) — updated Jul ۺŮ 2023ۺŮ
Categorisation of Urgency for Caesarean Section (C-Obs 14)ۺŮ
Delivery of Fetus at Caesarean Birth (C-Obs 37)ۺŮ
Instrumental Vaginal Birth (C-Obs 16)ۺŮ
Placenta Accreta Spectrum (PAS) (C-Obs 20) — updated Jul ۺŮ 2023ۺŮ
Management of Postpartum Haemorrhage (PPH)ۺŮ
Term Prelabour Rupture of Membranes (Term PROM) (C-Obs 36)ۺŮ
Care in Labour in the Absence of Pregnancy Complications (C-Obs 31) — updated Jul ۺŮ 2023ۺŮ
Timing of Elective Caesarean Section at Term (C-Obs 23)ۺŮ
Birth After Previous Caesarean Section (C-Obs 38)ۺŮ
Management of Breech Presentation (C-Obs 11)ۺŮ
Caesarean Birth on Maternal Request (CBMR) (C-Obs 39) — updated Jul ۺŮ 2023ۺŮ
Water Immersion During Labour and Birth (C-Obs 24) ۺŮ
Use of Prostaglandins for Induction of Labour (C-Obs 22) ۺŮ
Patient Blood Management Guidelines: Module 1 Critical Bleeding ۺŮ endorsed
Patient Blood Management Guidelines: Module 2 PerioperativeۺŮ endorsed
Patient Blood Management Guidelines: Module 3 MedicalۺŮ endorsed
Patient Blood Management Guidelines: Module 4 Critical CareۺŮ endorsed
Patient Blood Management Guidelines: Module 5 Obstetrics and MaternityۺŮ endorsed
Misoprostol for the Treatment of Postpartum Haemorrhage in Low
Resource Settings
Useful Clinical
Guidance
Useful Clinical
Guidance
Prevention and Management of Postpartum HaemorrhageUseful Clinical
Guidance
Shoulder DystociaUseful Clinical
Guidance
The Investigation and Management of the Small–for–Gestational–Age FetusUseful Clinical
Guidance
Umbilical Cord ProlapseUseful Clinical
Guidance
The Management of Third- and Fourth-Degree Perineal TearsUseful Clinical
Guidance
Clinical Practice Guideline For the Prevention of Venous
Thromboembolism in Patients Admitted to Australian Hospitals
Useful Clinical
Guidance

Medical disorders in pregnancy

Diagnosis of Gestational Diabetes Mellitus (GDM) (C-Obs 7) — under reviewۺŮ
Diagnosis and Management of Suspected Fetal Macrosomia (C-Obs 65)ۺŮ
Vasa Praevia (C-Obs 47)ۺŮ
ۺŮ endorsed
ADIPS Consensus Guidelines for the Testing and Diagnosis of
Hyperglycaemia in Pregnancy in Australia and New Zealand
Useful Clinical
Guidance
Guideline for the Management of Hypertensive Disorders of PregnancyUseful Clinical
Guidance
The Classification, Diagnosis and Management of the Hypertensive
Disorders of Pregnancy: A Revised Statement from the ISSHP
Useful Clinical
Guidance
Useful Clinical
Guidance
Management of Sickle Cell Disease in PregnancyUseful Clinical
Guidance

Models of care

Obstetric and Gynaecology Services in Rural and Remote Regions in AustraliaۺŮ
National Midwifery Guidelines for Consultations and Referral ۺŮ endorsed

Multiple pregnancy

Management of Monochorionic Twin Pregnancy (C-Obs 42)ۺŮ

Perinatal mental health

Mental Health Care in the Perinatal Period (C-Obs 48)ۺŮ
Psychosocial Assessment and Depression Screening in
Perinatal Women
ۺŮ endorsed

Pre-pregnancy care

Genetic Carrier Screening (C-Obs 63) ۺŮ
Pre-pregnancy Counselling (C-Obs 3a) — under reviewۺŮ
Prevention of Congenital Cytomegalovirus (CMV) Infection (C-Obs 64) — interim update Jul ۺŮ 2023ۺŮ

Red cell iso-immunisation and Rh(D) prophylaxis

Guidelines for the Use of Rh(D) Immunoglobulin (Anti-D) in Obstetrics (C-Obs 6)ۺŮ
Use of RH(D) Immunoglobulin in Patients with a Body Mass Index >30ۺŮ endorsed
Use of RH(D) Immunoglobulin (Anti-D Immunoglobulin) During Pregnancy
and the Post Partum Period
Useful Clinical
Guidance
Review and Update of the 2003 Guidelines on the Prophylactic Use of RH(D) Immunoglobulin (Anti-D) in ObstetricsUseful Clinical
Guidance
The Management of Women with Red Cell Antibodies During PregnancyUseful Clinical
Guidance

Routine antenatal care

Measurement of Cervical Length for Prediction of Preterm Birth (C-Obs 27)ۺŮ
Maternal Group B Streptococcus in Pregnancy: Screening and Management (C-Obs 19)ۺŮ
Management of Obesity in Pregnancy (C-Obs 49)ۺŮ
Prenatal Assessment of Fetal Structural Conditions (C-Obs 60) — under reviewۺŮ
Prenatal Screening and Diagnostic Testing for Fetal Chromosomal and Genetic Conditions (C-Obs 59) — under reviewۺŮ
Prenatal Screening for Fetal Genetic or Structural Condition (C-Obs 35) — under reviewۺŮ
Pre-Pregnancy and Pregnancy Related Vaccinations (C-Obs 44) — updated Mar ۺŮ 2023ۺŮ
Progesterone Support of the Luteal Phase and in the First Trimester (C-Obs 29a)ۺŮ
Progesterone: Use in the Second and Third Trimester of Pregnancy for the Prevention of Preterm Birth (C-Obs 29b)ۺŮ
Routine Antenatal Assessment in the Absence of Pregnancy Complications (C-Obs 3b)ۺŮ
Early Pregnancy Screening and Prevention of Preterm Preeclampsia and Related Complications (C-Obs 61) — updated Apr 2024ۺŮ
Subclinical Hypothyroidism and Hypothyroidism in Pregnancy (C-Obs 46)ۺŮ
Vitamin and Mineral Supplementation and Pregnancy (C-Obs 25)ۺŮ
Supporting Smoking Cessation During Pregnancy – Nicotine Replacement Therapy (NRT)ۺŮ endorsed
Supporting Smoking Cessation During Pregnancy – Nicotine Replacement Therapy (NRT) 1ۺŮ endorsed
Guidance for Healthy Weight Gain in PregnancyUseful Clinical
Guidance
Third Trimester Fetal Growth Scan Reporting TemplateUseful Clinical
Guidance
Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult HealthUseful Clinical
Guidance

The neonate

Responsibility for Neonatal Resuscitation at Birth (C-Obs 32) — interim update Mar ۺŮ 2023ۺŮ
Prevention, Detection, and Management of Subgaleal Haemorrhage in the Newborn (C-Obs 28)ۺŮ
Vitamin K Administration to Newborn Infants to Prevent Vitamin K Deficiency Bleeding in InfancyۺŮ endorsed
Circumcision of Infant MalesUseful Clinical
Guidance


Gynaecology

Cervical screening and cancer

Cervical Cancer Screening in Australia and New Zealand (C-Gyn 19)ۺŮ
Vaginal Screening After Hysterectomy in Australia (C-Gyn 8)ۺŮ
Guidelines for HPV Vaccine (C-Gyn 18)ۺŮ
Vaginal Screening After Hysterectomy in New Zealand (C-Gyn 8b)ۺŮ
Staging Classification for Cancer of the Ovary, Fallopian tube, and PeritoneumUseful Clinical
Guidance

Contraception

Depot Medroxyprogesterone Acetate (C-Gyn 04) — under reviewۺŮ
Emergency Contraception (C-Gyn 11) — under reviewۺŮ
Reproductive Health for Women with an Intellectual Disability (C-Gyn 10)ۺŮ
Intrauterine Contraception (C-Gyn 3) — under reviewۺŮ
Long Acting Reversible Contraception (C-Gyn 34) — under reviewۺŮ
Combined Hormonal Contraceptives (C-Gyn 28) — under reviewۺŮ
Long Acting Reversible Contraception (LARC) – Consensus StatementۺŮ endorsed
Medical Eligibility Criteria for Contraceptive Use (WHO) (FSRH)Useful Clinical
Guidance
Contraception After PregnancyUseful Clinical
Guidance
Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive PillsUseful Clinical
Guidance

Endometriosis

Endometriosis Clinical Practice GuidelineۺŮ

Gynaecological surgery and procedures

Female Genital Mutilation/Cutting (FGM/C) (C-Gyn 1) — updated Mar ۺŮ 2023ۺŮ
Gynaecological Examinations and Procedures (C-Gyn 30)ۺŮ
Management of Gestational Trophoblastic Disease (C-Gyn 31)ۺŮ
Managing the Adnexa at the Time of Hysterectomy for Benign Gynaecological Disease (C-Gyn 25) — updated Mar ۺŮ 2023ۺŮ
Permanent Female Contraception Filshie Clip Tubal Occlusion (C-Gyn 22) — interim update Jul ۺŮ 2023ۺŮ
Polypropylene Vaginal Mesh Implants for Vaginal Prolapse (C-Gyn 20)ۺŮ
Position Statement on Midurethral Slings (C-Gyn 32)ۺŮ
Position Statement on Robotic-Assisted Laparoscopy (C-Gyn 29)ۺŮ
Power Morcellation at Minimally Invasive Procedures (C-Gyn 33) (previously ‘Tissue Extraction’)ۺŮ
Sacrocolpopexy Clinical Guidance Statement (C-Gyn 37)ۺŮ
Use of the Veress Needle to Obtain Pneumoperitoneum Prior to Laparoscopy (C-Gyn 7)ۺŮ
Uterine Artery Embolisation for the Treatment of Uterine Fibroids (C-Gyn 23)ۺŮ
Vaginal ‘Rejuvenation’ and Cosmetic Vaginal Procedures (C-Gyn 24)ۺŮ
National Elective Surgery Urgency CategorisationۺŮ endorsed
The Initial Management of Chronic Pelvic PainUseful Clinical
Guidance

Menopause

Tamoxifen and the Endometrium (C-Gyn 12)ۺŮ
Managing Menopausal SymptomsۺŮ
A Practitioner’s Toolkit for Managing the MenopauseUseful Clinical
Guidance

Menstrual disorder

Investigation of Intermenstrual and Postcoital Bleeding (C-Gyn 6)ۺŮ

Paediatric and adolescent gynaecology

Genital Examinations in Girls and Young Women: A Clinical Practice GuidelineۺŮ endorsed

Reproductive endocrinology

Fibroids in Infertility (C-Gyn 27)ۺŮ
Useful Clinical
Guidance

Sexual and reproductive health

Clinical Guideline for Abortion Care — updated Oct ۺŮ 2023ۺŮ
Cross-Border Reproductive Care (C-Gyn 36)ۺŮ
ۺŮ endorsed
Useful Clinical
Guidance
Useful Clinical
Guidance
Useful Clinical Guidance


ۺŮ

Guidelines for ۺŮ in Advanced Endoscopic Surgery (C-Trg 1)ۺŮ
Guidelines for Performing Gynaecological Endoscopic pPocedures (C-Trg 2)ۺŮ
Clinical ۺŮ Whilst Pregnant (C-Trg 7)ۺŮ
ۺŮ ۺŮ Registrar Supervision Guideline (C-TRG 05)ۺŮ
Use of Lasers in Obstetrics and Gynaecology (C-Trg 4)ۺŮ

General

Clinical governance

Maternal and Perinatal Data Collection (C-Obs 40)ۺŮ
Clinical Practice Guideline for Perinatal MortalityۺŮ endorsed
Health Care of Asylum Seekers and Refugees – 2011ۺŮ endorsed

Issues common to obstetrics and gynaecology

Driving After Abdominal Surgery Including Caesarean Section (C-Gen 21)ۺŮ
Prophylactic Antibiotics in Obstetrics and Gynaecology (C-Gen 17)ۺŮ
Smoking and Pregnancy (C-Obs 53) — under reviewۺŮ
Assessing Fitness to DriveۺŮ endorsed
Acute Pain Management: Scientific EvidenceUseful Clinical
Guidance
Helping People to Stop SmokingUseful Clinical
Guidance

General

Assessment of Competency (C-Gen 09)ۺŮ
Attributes of a ۺŮ Fellow (C-Gen 19)ۺŮ
Consent and Provision of Information to Patients in New Zealand Regarding Proposed Treatment (C-Gen 2b)ۺŮ
Consent and Provision of Information to Patients in Australia Regarding Proposed Treatment (C-Gen 2a)ۺŮ
Position Statement on the Appropriate Use of Diagnostic Ultrasound (C-Gen 10)ۺŮ
Evidence-Based Medicine, Obstetrics and Gynaecology (C-Gen 15)ۺŮ
ۺŮ Position Statement Health of Women Seeking Asylum, Refugees and Women Held in DetentionۺŮ
Performance of Sexual Assault Forensic Examinations by ۺŮ Trainees (C-Gen 12)ۺŮ
The ۺŮ Expert Witness Register: Guidelines for College Members Providing Expert Opinion (C-Gen 01)ۺŮ
Surrogacy in Australia and New Zealand (C-Gen 16)ۺŮ
Guidelines for Visiting Surgeons Conducting Demonstration Sessions (C-Gen 6)ۺŮ
Statement on Climate Change (2019)ۺŮ
Statement on Prolonged Exposure to Bushfire Smoke and Poor Air Quality (2020)ۺŮ
Ensuring the Health and Well-Being of Every Woman, Child, Newborn and AdolescentۺŮ endorsed
ۺŮ endorsed
ۺŮ endorsed
Climate Change and Women’s Health (AMA)ۺŮ endorsed
Communication Between Eligible Midwives and Obstetricians (GP or Specialist)Useful Clinical
Guidance
The Prevention and Elimination of Disrespect and Abuse During Facility-Based ChildbirthUseful Clinical
Guidance
Sexuality-Related CommunicationUseful Clinical
Guidance


Disclaimer

ۺŮ reviews clinical guidelines, statements, and patient information pamphlets on a five-year rotation, notwithstanding special circumstances. The number of documents that require review in any given year is large and on occasion we are unable to complete all of them within the designated time frame. Some of these documents will not require updating at the time they are reviewed. In these cases, the version date and year for next review will be updated, but the content remains unchanged.     

The ‘due for review date’ on a document is an administrative tool that helps us to keep track of our information resources. It does not mean that the information is no longer relevant once the review date has passed. The information within these documents does not expire, but changes to treatments, practices and advice can change over time, which is why ۺŮ regularly reviews and updates them (if necessary). The information provided in these documents is of a general nature and should not be seen as a substitute for medical advice or assessment by a doctor. An individual’s specific circumstances should always be considered when medical decisions are made. 

 ۺŮ will prioritise information for review if the circumstances warrant it.


Request archived documents

NEED TO ACCESS ARCHIVED CONTENT?

Updated
15 July 2024
SHARE


FOR CONSUMERS

Patient information resources

Browse our library of information on specific health concerns or medical procedures, written by expert specialist doctors.

Raising Awareness Tool for Endometriosis (RATE)


LATEST NEWS

the College 10 July 2024
Consumer Engagement Framework (CEF) Project
The ۺŮ Consumer Engagement Framework (CEF) will establish the foundations…
Advocacy 17 June 2024
New Zealand Women Would Benefit From Pelvic Floor Muscle ۺŮ 
New Zealand’s obstetricians and gynaecologists are increasingly concerned about pelvic…
Advocacy 31 May 2024
Now More Than Ever: National Reconciliation Week 2024
National Reconciliation Week (NRW) is a crucial time in Australia…
Advocacy 31 May 2024
Insights from the Aotearoa New Zealand Budget 2024
The Aotearoa New Zealand Government has released its 2024-2025 budget.